|
× |
 |
VYNDAMAX (tafamidis) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
VELPHORO (ferric oxyhydroxide) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
AVYCAZ (avibactam sodium; ceftazidime) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
ZONTIVITY (vorapaxar sulfate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
POLYETHYLENE GLYCOL 8000 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SORBITOL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
LACTOSE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SULFURIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
|